Matches 1 - 50 out of 148 1 2 3 >


Match Document Document Title
8138174 Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition  
Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition, pharmaceutical compositions containing these compounds, methods for preparing these compounds, methods...
8088797 Substituted N-(4-cyano-1H-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof  
The present invention relates to compounds corresponding to formula (I): Wherein X, R1, R2, R3 and R4 are as defined herein. The invention further relates to preparation and therapeutic use of...
7989485 Imidazole compounds having pharmaceutical activity towards the sigma receptor  
The present invention relates to compounds of formula (I), methods for their preparation, medicaments comprising these compounds as well their use in the manufacture of a medicament for the...
7902239 Diaminotriazoles useful as inhibitors of protein kinases  
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the...
7897589 Substituted pyrazoline compounds, their preparation and use as medicaments  
The present invention relates to substituted pyrazoline compounds, methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for...
7834046 Thiophene compounds  
This invention relates to thiophene compounds of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to treat cannabinoid-receptor...
7790711 Inhibitors of 11β-Hydroxysteroid Dehydrogenase  
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and...
7524838 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them  
The present invention relates to the novel derivatives of formula (I) in which A is, if it is present, a (C1-C6) alkyl, a (C3-C6) alkenyl, a (C3-C6) alkynyl, a (C3-C7) cycloalkyl or a (C5-C7)...
7468363 Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione  
Methods of treating a specific cancer or amyloidosis are disclosed. Specific methods encompass the administration of 3-(4-amino-1 oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione alone or in...
7429607 5-HT2B receptor antagonists  
The present invention relates to compounds of formula I: wherein one of R1 and R4 is selected from the group consisting of H, and optionally substituted C1-6 alkyl, C3-7 cycloalkyl, C3-7...
7405209 Protease inhibitors  
The present invention provides 4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K,...
7368445 Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms  
The disclosed invention is directed to compounds of the formula: Formula (I) and methods of using these compounds.
7329652 Diaminotriazole compounds useful as protein kinase inhibitors  
The present invention relates to inhibitors of protein kinases, particularly to inhibitors of JAK2 and JAK3. The invention also provides pharmaceutical compositions comprising the compounds of the...
7304052 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants  
The present invention relates to compounds of formula (I) their prodrugs, N-oxides, addition salts, quaternary amines and stereochemically isomeric forms, wherein the bivalent radical -{circle...
7279469 Diaminotriazoles useful as inhibitors of protein kinases  
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the...
7273882 Aminoacetamide acyl guanidines as β-secretase inhibitors  
There is provided a series of substituted acyl guanidines of Formula (Ik) or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R2, R3, R4, R5, R25, R26 and R27 as defined...
7265102 Substituted pyrazoles  
Substituted pyrazoles of general formula methods of manufacturing them, compositions containing them, and methods of using them to, for example, treat autoimmune diseases mediated by cathepsin S,...
7125877 Benzimidazole derivatives  
This invention provides compounds which are represented by a general formula [I] [in which X stands for hydrogen or halogen; B stands for halogen, cyano or optionally fluorine-substituted lower...
7071184 Protease inhibitors  
The present invention provides C1-6alkyl-4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin...
7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor  
The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or...
7041668 Substituted benzimidazole compounds and their use for the treatment of cancer  
The present invention discloses and claims benzimidazole compounds of formula (I): in which A is aryl or heteroaryl; R1 is selected from optionally substituted alkyl, alkoxy, aryl or heteroaryl,...
7030150 Benzimidazole compounds and antiviral uses thereof  
The present invention relates to novel benzimidazole compounds that have useful antiviral activity. More specifically, the invention encompasses benzimidazole compounds that inhibit membrane fusion...
7001901 Tetrazolylpropionamides as inhibitors of Aβ protein production  
This invention relates to novel tetrazolyl-propionamides in which the amide group comprises an aminoazepinone, and related structures, of Formula (I): or pharmaceutically acceptable salt or prodrug...
6953793 Substituted pyrazoles  
Substituted pyrazoles, methods of manufacturing them, compositions containing them, and methods of using them to treat, for example, autoimmune diseases mediated by cathepsin S are described.
6906090 Compositions and methods for treating mycobacterial diseases  
The invention provides the use of certain isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease.
6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes  
This application is directed to compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic...
6887864 Azepane derivatives  
This invention provides novel azepane derivatives or pharmaceutically acceptable salts thereof, according to the general formula (I) wherein the symbols are defined in the specification, as well as...
6887865 N-heterocyclic derivatives as NOS inhibitors  
N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds,...
6869945 Pyrrolyl-and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes  
This application is directed to compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic...
6861432 Piperazine derivatives that destabilize androgen receptors  
This invention relates to new piperazine derivatives of general formula I, in which V, W, n, R, R′, i, j, Y and Z have the meaning that is indicated in the description. The compounds according to t...
6828315 1-Amino triazoloc4,3-a&excl quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV  
The present invention relates to triazolo[4,3-a]quinazoline-5-ones and 5-thiones of Formula I and Formula II, whereby I and II are position isomers of group R on nitrogen 3 or 4. Optionally, the...
6720317 Inhibitors of factor Xa  
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating...
6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them  
Compounds of formula (I) are useful as human NK3 receptor antagonists.
6696437 Heterocyclically substituted benzimidazoles, the production and application thereof  
The present invention relates to novel benzimidazoles, their preparation and their use as inhibitors of the enzyme poly(ADP-ribose) polymerase or PARP (EC 2.4.2.30) for producing drugs.
6667303 Aryl substituted 1,4-diazepanes and method of use thereof  
Aryl substituted 1,4-diazepanes are provided such as derivatives of 6-(1,4-diazepan-1-yl)benzo[cd]indol-2(1H)-one, 6-(1,4-diazepan-1-yl)acenaphthylen-1(2H)-one and...
6627624 Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors  
Disclosed are compounds of the formula: or the pharmaceutically acceptable non-toxic salts thereof wherein the A, B, C, D, X, R1, R2, R3, R4, R5, and R6, are variables defined herein, which...
6613781 Heterocyclylaklylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands  
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor
6420395 Azacyclooctane and heptane derivatives, their preparation and use in therapy  
The present invention discloses compounds of formula (1) or (2), any of its enantiomers or any mixture thereof, or a pharmaceutically acceptable salt thereof; wherein n is 0, or 1; R is hydrogen,...
6365584 Arylysulphonamide-substituted benzimidazoles having tryptase-inhibiting activity  
Arylsulphonamide-substituted benzimidazole derivatives of formula (I) having tryptase-inhibiting activity. Exemplary...
6352981 Substituted AZA- and diazacycloheptane and -cyclooctane  
Aza- and diazacyclohexane and -cyclooctane compounds of the following formula: Ar1—A—B—Ar2 (I)where Ar1, A, B and Ar2 have the meanings stated in the description have a high affinity for the dopam...
6251921 Antithrombotic diamines  
This application relates to the use as thrombin inhibitors, coagulation inhibitors and thromboembolic disorder agents of diamines of formula I as defined herein. It also provides novel compounds of...
6133291 N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists  
The present invention discloses novel N(imidazolylalkyl)-substituted cyclic amine compounds which have excellent histamine-H3 receptor antagonist activity as well as methods for preparing such...
6107291 Azepine or larger medium ring derivatives and methods of use  
Selected novel azepine and larger medium ring compounds are effective for prophylaxis and treatment of inflammation, tissue degradation and related diseases. The invention encompasses novel...
6100279 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom  
Disclosed are compounds of Formula I ##STR1## or pharmaceutically acceptable salts or solvates thereof. Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable...
6096746 Indazole compound containing a monocyclic amine structure  
An indazole compound having a piperazinyl moiety in the structure thereof, which is a 5-HT4 receptor agonist which is useful in the treatment of digestive tract disorders.
6030992 Methods of treating or preventing sleep apnea  
6025333 Treatment of CNS tumors with metalloprotease inhibitors  
The present invention relates to genes and their encoded proteins which regulate neurite growth and the diagnostic and therapeutic use of such proteins (termed herein neurite growth regulatory...
6022868 Substituted azacyclic or azabicyclic compounds  
5994347 For a process for treatment of anxiety and tension  
A process for the treatment of anxiety and tension, which comprises administering to a patient in need therefor an anxiolytically effective amount of a compound of the formula ##STR1## wherein X is...
5972975 Substituted 2-aminopyridines as inhibitors of nitric oxide synthase  
Substituted 2-aminopyridine compounds of Formula (I) and pharmaceutically acceptable salts which have been found useful in the treatment of nitric oxide synthase mediated diseases and disorders....
Matches 1 - 50 out of 148 1 2 3 >